Kobayashi H - Search Results

1

Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.

Onogi H, Minatoguchi S, Chen XH, Bao N, Kobayashi H, Misao Y, Yasuda S, Yamaki T, Maruyama R, Uno Y, Arai M, Takemura G, Fujiwara H. Onogi H, et al. Among authors: kobayashi h. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1035-41. doi: 10.1111/j.1440-1681.2006.04483.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17042911

2

Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction.

Nagai H, Minatoguchi S, Chen XH, Wang N, Arai M, Uno Y, Lu C, Misao Y, Onogi H, Kobayashi H, Takemura G, Maruyama R, Fujiwara T, Fujiwara H. Nagai H, et al. Among authors: kobayashi h. Hypertens Res. 2005 Apr;28(4):361-8. doi: 10.1291/hypres.28.361. Hypertens Res. 2005. PMID: 16138567

3

Nicorandil improves post-ischemic myocardial dysfunction in association with opening the mitochondrial K(ATP) channels and decreasing hydroxyl radicals in isolated rat hearts.

Lu C, Minatoguchi S, Arai M, Wang N, Chen XH, Bao N, Kawamura I, Yasuda S, Kobayashi H, Wu DJ, Takemura G, Fujiwara H. Lu C, et al. Among authors: kobayashi h. Circ J. 2006 Dec;70(12):1650-4. doi: 10.1253/circj.70.1650. Circ J. 2006. PMID: 17127815 Free article.

4

Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits.

Bao N, Minatoguchi S, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Arai M, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H. Bao N, et al. Among authors: kobayashi h. Circ J. 2007 Oct;71(10):1622-8. doi: 10.1253/circj.71.1622. Circ J. 2007. PMID: 17895562 Free article.

5

In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.

Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M, Wang N, Misao Y, Lu C, Onogi H, Kobayashi H, Yasuda S, Ezaki M, Ushikoshi H, Takemura G, Fujiwara T, Fujiwara H. Chen XH, et al. Among authors: kobayashi h. J Card Fail. 2007 Dec;13(10):874-83. doi: 10.1016/j.cardfail.2007.07.004. J Card Fail. 2007. PMID: 18068622

6

Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.

Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Tabata Y, Fujiwara H. Kobayashi H, et al. Cardiovasc Res. 2008 Sep 1;79(4):611-20. doi: 10.1093/cvr/cvn154. Epub 2008 Jun 9. Cardiovasc Res. 2008. PMID: 18541523

7

Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits.

Bao N, Ushikoshi H, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Nagashima K, Aoyama T, Kawasaki M, Nishigaki K, Takemura G, Minatoguchi S. Bao N, et al. Among authors: kobayashi h. J Cardiol. 2009 Feb;53(1):102-7. doi: 10.1016/j.jjcc.2008.09.012. Epub 2008 Nov 25. J Cardiol. 2009. PMID: 19167645 Free article.

8

Acarbose reduces myocardial infarct size by preventing postprandial hyperglycemia and hydroxyl radical production and opening mitochondrial KATP channels in rabbits.

Minatoguchi S, Zhang Z, Bao N, Kobayashi H, Yasuda S, Iwasa M, Sumi S, Kawamura I, Yamada Y, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H. Minatoguchi S, et al. Among authors: kobayashi h. J Cardiovasc Pharmacol. 2009 Jul;54(1):25-30. doi: 10.1097/FJC.0b013e3181a98b53. J Cardiovasc Pharmacol. 2009. PMID: 19487955

9

Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.

Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Kobayashi H, et al. J Cardiovasc Pharmacol. 2009 Dec;54(6):510-9. doi: 10.1097/FJC.0b013e3181bfac02. J Cardiovasc Pharmacol. 2009. PMID: 19755919

10

Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.

Iwasa M, Kobayashi H, Yasuda S, Kawamura I, Sumi S, Yamada Y, Shiraki T, Yamaki T, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Iwasa M, et al. Among authors: kobayashi h. J Cardiovasc Pharmacol. 2010 Jun;55(6):625-34. doi: 10.1097/FJC.0b013e3181dcd240. J Cardiovasc Pharmacol. 2010. PMID: 20351564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,540 results

Search Page

Filters